Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (12): 1394-1396.

Previous Articles     Next Articles

Meta-analysis on combination of growth hormone and somatostain and single somatostain in treatment of patients with severe acute pancreatitis

ZHU Liang-hong, LI Juan1, ZHAO Guo-hai   

  1. Department of Emergency Surgery;
    1Centre forDrug Clinical Evaluation,Wannan Medical CollegeYijishanHospital,Wuhu 241001,Anhui,China
  • Received:2005-12-20 Revised:2005-12-30 Online:2005-12-26 Published:2020-11-11

Abstract: AIM: To explore the difference of efficacy and safety between combination of growth hormone and somatostain and single somatostain in treatment of patients with severe acute pancreatitis.METHODS: The case fatality rates and complication incidence of patients with severe acute pancreatitis were analyzed by Meta-analysis in homogeneity test and combined test in 6 studies.RESULTS: Homogeneity test showed that the cited studies of case fatality rates and complication incidence were homogeneous withχ2 =3.156,χ2 =1.210,P>0.05.In combined test,the combined Or=3.164,Or=3.209 and its 95 % confidence interval was in 1.390 ~ 7.200 and 1.747 ~ 5.900,respectively.CONCLUSION: The case fatality rates in combination grouPwere significantly lowerthan those in single somatostain group.The efficacy of combination grouPwas superiorto that of single somatostain group.

Key words: Meta-analysis, growth hormone, somatostain, pancreatitis, recombination, fatality rate, complication

CLC Number: